| 000 | 01815 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515001212.0 | ||
| 264 | 0 | _c20060117 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s00280-005-0028-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrari, Vittorio | |
| 245 | 0 | 0 |
_aGemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cJan 2006 |
||
| 300 |
_a185-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCelecoxib |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aValcamonico, Francesca | |
| 700 | 1 | _aAmoroso, Vito | |
| 700 | 1 | _aSimoncini, Edda | |
| 700 | 1 | _aVassalli, Lucia | |
| 700 | 1 | _aMarpicati, Patrizia | |
| 700 | 1 | _aRangoni, Giovanni | |
| 700 | 1 | _aGrisanti, Salvatore | |
| 700 | 1 | _aTiberio, Guido A M | |
| 700 | 1 | _aNodari, Franco | |
| 700 | 1 | _aStrina, Carla | |
| 700 | 1 | _aMarini, Giovanni | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 57 _gno. 2 _gp. 185-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-005-0028-1 _zAvailable from publisher's website |
| 999 |
_c15786205 _d15786205 |
||